A/Prof Anne Hamilton
Honorary Conjoint Principal Fellow
The Sir Peter MacCallum Department of Oncology
154 Scholarly works
1 Projects
HIGHLIGHTS
2026
Journal article
REAL-WORLD OUTCOMES OF THE INTERLACE PROTOCOL FOR HIGH-RISK LOCALLY ADVANCED CERVICAL CANCER: A TERTIARY CENTRE EXPERIENCE WITH MODERN STAGING AND RADIOTHERAPY TECHNIQUE
DOI: 10.1016/j.ijgc.2026.1052032026
Journal article
Real-World Experience of Cabozantinib in Relapsed Osteosarcoma and Ewing Sarcoma-A Single Center Retrospective Study.
DOI: 10.1111/ajco.701802026
Journal article
Real-World Trends and Outcomes for Localized High-Grade Soft Tissue Sarcoma: Insights from a Sarcoma Unit in Australia
DOI: 10.1111/ajco.700432026
Journal article
Clinical Utility of an RNA-based Gene Fusion Assay in Sarcoma for Diagnosis and Management: Experience in an Australian Laboratory
DOI: 10.1007/s40291-025-00820-72025
Conference Proceedings
Bowel obstruction in advanced malignancies: An evaluation of patient outcomes at a tertiary cancer centre
DOI: 10.1002/msp2.700272024
Research grants (other domestic)
Stereotactic Ablative Body Radiotherapy (SABR) for 4 Gynaecologic Metastases
2015
Journal article
Whole-genome characterization of chemoresistant ovarian cancer
DOI: 10.1038/nature14410
RECENT SCHOLARLY WORKS
2025
Journal article
Consensus guidelines for antibacterial prophylaxis in patients with neutropenia
DOI: 10.1111/imj.702502025
Conference Proceedings
2725P Real-world experience of cabozantinib monotherapy in relapsed or refractory osteosarcoma and Ewing Sarcoma: A single-centre Australian study
DOI: 10.1016/j.annonc.2025.08.33352025
Journal article
Nivolumab and Ipilimumab Combination Treatment in Advanced Ovarian and Endometrial Clear Cell Cancers: A Nonrandomized Clinical Trial
DOI: 10.1001/jamaoncol.2025.19162025
Journal article
Trends in Practice Patterns and Clinical Outcomes for Desmoid Tumors: A Large Single-Institutional Australian Cohort
DOI: 10.1002/cam4.709732024
Journal article
713MO Nivolumab and ipilimumab combination treatment in advanced gynaecological clear cell cancers: Results from the phase II MoST-CIRCUIT trial
DOI: 10.1016/j.annonc.2024.08.775